New Cancer Vaccine Harnesses COVID-19 Immunity to Fight Tumors

If you’ve had a COVID-19 vaccine, or caught the virus itself, part of your immune system already remembers exactly how to respond to it. New research suggests that memory could be redirected against something far more dangerous: cancer. Scientists have built a vaccine called PROTEXI that borrows your immune system’s playbook against COVID-19 and turns it on tumors instead — and in early lab testing, it’s managing to do something cancer vaccines have struggled with for decades. Here’s what that looks like, and why researchers are calling it a real turning point.

Why Most Cancer Vaccines Underdeliver

Your immune system fights cancer with two types of T cells. CD8 “killer” T cells attack and destroy tumor cells directly. CD4 “helper” T cells act like commanders — they point the killers toward the tumor, switch them on, and keep them fighting long enough to finish the job. You need both working together, or the vaccine falls flat.

Here’s the problem: most cancer vaccines only train the killers. They skip the commanders, because finding a commander target that’s unique to each patient’s tumor is hard and expensive. Every patient’s tumor mutations are different, and there’s no reliable way to predict which mutation will make a good target for the helper cells. So most vaccines end up training an army with nobody leading it. The result: only about 15% of patients respond to these vaccines, even though roughly 200 clinical trials have shown they’re safe to use.

Researchers at University Hospitals Rainbow Babies & Children’s Hospital in Ohio, led by Dr. John Letterio, found a clever way around this problem. Instead of hunting for a brand-new commander for every patient, why not use commanders that are already trained and waiting? Nearly everyone today has immune memory against the COVID-19 spike protein, thanks to vaccination, infection, or both. Those memory cells are a type of CD4 helper T cell — already primed and ready to act. You just have to point them at a new target. More than 80% of people in the US, and roughly 65% of people worldwide (over 5.1 billion), carry this immunity. That’s a massive, ready-made resource sitting untapped. As Letterio put it, this is “something that has never really been achievable with cancer vaccines before.”

That idea became PROTEXI — and it’s the foundation for everything else in this new approach to cancer vaccines.

How PROTEXI Actually Works

The vaccine starts with cells from your own body. Doctors draw a blood sample and pull out dendritic cells — the immune system’s trainers. Their normal job is to grab a piece of something dangerous, break it down, and show it to your T cells so they know exactly what to attack.

In the lab, scientists load those dendritic cells with two pieces of information at once. The first is a small piece of your tumor’s own proteins — this teaches the killer T cells what to hunt. The second is a small piece of the COVID-19 spike protein — this calls in the commanders your immune system already has on standby. Once the cells are trained, they’re injected back into your body.

That second piece — loading both signals onto the same cell — turns out to matter a great deal. In lab tests, mice given this combined vaccine mounted a stronger, longer-lasting attack on their tumors than mice given two separate vaccines, one loaded with the tumor piece and one loaded with the COVID piece. Handing the immune system a single cell carrying both messages seems to be the key. It gets the killers and commanders working in the same place at the same time, instead of showing up separately. The result, according to Letterio’s team, is an immune response that’s stronger and far better coordinated than anything a single-signal vaccine can produce.

This is a different strategy than the mRNA cancer vaccines you may have heard of, developed by companies like BioNTech and Moderna. Those vaccines carry short-lived genetic instructions that tell your own cells to build a protein your immune system can then react to. PROTEXI skips that step entirely. It uses your actual dendritic cells as delivery vehicles, already carrying the finished message your immune system needs to act on. Both approaches are personalized — mRNA vaccines through sequencing the genes in your tumor, PROTEXI through using your own cells directly — but they get there through very different routes.

What Happened When Scientists Tested It

Here’s something researchers didn’t fully expect. Once PROTEXI gets the immune system moving, it doesn’t stop at the exact tumor pieces it was given. It starts recognizing other parts of the same tumor on its own — targets that were never loaded onto the vaccine at all. Scientists call this “epitope spreading.” In one experiment, mice were vaccinated against just two or three specific tumor targets. When researchers checked what the immune system was actually attacking afterward, it had expanded on its own to include tumor proteins that were never part of the vaccine to begin with. It caught the research team off guard — enough that they’ve pointed to it as a turning point in the project.

Why does this matter? Tumors are good at hiding. They shift and mutate constantly, which lets them dodge a treatment aimed at just one or two fixed targets. A vaccine that can widen its own target list on the fly has a real edge over one that can’t.

The lab results back this up. In mouse models of both melanoma and breast cancer, PROTEXI slowed tumor growth and extended survival more effectively than a standard dendritic cell vaccine — the kind that targets only the tumor piece, without the COVID-19 booster signal. The protection also held up over time. Mice whose tumors were brought under control by PROTEXI were exposed to fresh tumor cells weeks later, and they rejected those too, with no additional treatment. Their immune systems simply remembered how to fight.

Researchers pushed this a step further. They took immune cells from mice that had survived PROTEXI and transferred them into brand-new mice that had never been vaccinated. Those mice resisted tumor growth as well. That tells you the vaccine isn’t just working in the moment — it’s building a lasting, transferable memory that keeps working long after the original treatment ends.

Beating Treatment Resistance — And Proving It Works On Human Cells

Not every tumor responds to today’s best cancer therapies, even the ones that have transformed treatment for millions of people. Checkpoint inhibitors like anti-PD-1 drugs work by releasing the brakes on T cells so they can attack more aggressively. But plenty of tumors ignore them completely — including a well-known lab model of melanoma that researchers use specifically because it resists this kind of treatment.

That’s the tumor researchers tested PROTEXI against next. On its own, PROTEXI slowed the growth of this treatment-resistant tumor. Combined with anti-PD-1, the effect got stronger still — tumors shrank further, and mice survived longer than with either treatment alone. The vaccine appears to wake up exhausted T cells sitting inside the tumor, cells that had essentially given up the fight, and gets them producing tumor-killing chemicals again.

Researchers ran a similar test with a drug called Vactosertib, which blocks a tumor signal called TGF-beta. Tumors release TGF-beta to keep nearby tissue calm and immune cells away — it’s one of their main tricks for staying hidden. Vactosertib alone didn’t slow this tumor down at all. Paired with PROTEXI, though, tumor growth slowed significantly, mice lived longer, and a quarter of the treated group stayed tumor-free for more than 50 days. That’s a real result in a tumor model built specifically to resist treatment.

Then came the most important test: would any of this hold up with real human immune cells? Researchers built mice with a human immune system, using blood from a donor who’d been vaccinated against COVID-19. They implanted human melanoma cells carrying two known tumor markers, then vaccinated the mice with a human version of PROTEXI. Tumor growth slowed significantly compared to untreated mice, or mice given a standard vaccine without the COVID-19 component. Blood tests confirmed a clear jump in T cells reacting to the COVID-19 spike protein, with early signs — not yet statistically significant, but a promising trend — that the tumor-specific T cells were reacting too. It’s still early-stage evidence, done in mice carrying human cells rather than in actual patients. But it’s the clearest sign yet that this approach could make the leap from the lab to the clinic.

My Personal RX on Building a Stronger Immune System

The vaccine science you just read about depends on one remarkable fact: your immune system remembers. It holds onto a record of past threats for years, ready to spring into action the moment it recognizes one again. Researchers spend years in a lab trying to engineer that kind of memory. The good news is you’re already building or breaking down yours every day, through choices most people never connect to their immune health. Here are ten things I actually tell my patients — not vague wellness talk, but habits you can start this week.

1. Pick one night this week to go to bed 30 minutes earlier: Your immune system does most of its “filing” of memory cells during deep sleep, so consistently running on 5-6 hours quietly weakens that process. If your mind won’t shut off once you’re in bed, a supplement like Sleep Max — magnesium, GABA, and 5-HTP — can help you get to deep sleep faster instead of tossing and turning.
2. Check your vaccine record next time you’re at the pharmacy: Flu shot, COVID booster, shingles if you’re over 50 — each one adds a trained layer to your immune memory, the same basic principle researchers are now trying to turn against cancer. Most people are behind on at least one without realizing it.
3. Notice when you’re dragging by 3pm, and don’t just reach for coffee: That afternoon crash is often your cells running low on the energy they need to keep working, immune cells included. I recommend CoQ10 to patients who deal with this regularly — it supports cellular energy production and helps protect your cells from everyday wear and tear, so you’re not running your immune system on empty.
4. Get 10 minutes of actual sunlight on your skin before 10am, when you can: It’s the simplest way to support your vitamin D levels, and most of my patients test low, especially by late winter. If sunlight isn’t realistic where you live, a D3 with K2 and magnesium covers both bone and immune support in one supplement — I keep a bottle on my own kitchen counter.
5. Pick one stress trigger you can actually change this month — not everything at once: Chronic stress keeps cortisol elevated, and that quietly dulls immune function over time. You don’t need to overhaul your life. Cutting one recurring stressor, even something small like a dreaded weekly meeting you can delegate, moves the needle.
6. Take a 20-minute walk after dinner instead of sitting on the couch: You don’t need a gym membership. Moderate movement most days keeps immune cells circulating and patrolling your body instead of sitting idle — and a post-dinner walk is one most people can actually stick with.
7. Add one extra colorful food to your plate today, not a whole diet overhaul: A handful of berries, a bell pepper, whatever’s in season. Small, repeatable swaps beat a strict plan you’ll abandon in two weeks.
8. Keep a water bottle where you’ll actually see it: Most people I ask can’t tell me how much water they drank yesterday. Your lymphatic system, which moves immune cells around your body, needs you hydrated to work well — and this is the easiest fix on this list.
9. If it’s been over a year, get your cholesterol and blood pressure checked: Heart health and immune health are more connected than most people assume — poor circulation means immune cells take longer to reach where they’re needed. A daily omega-3 fish oil is something I recommend often here, since it supports both heart and cognitive health at once.
10. Call one person you’ve been meaning to call, today: This isn’t a throwaway line — chronic loneliness is genuinely linked to weaker immune function. It’s a real health habit, not just a nice-to-have.

None of this requires a lab or a prescription. Pick two from this list and start there. Your immune system is already paying attention.

Sources:

1. Kang, J. M., Han, E. H., Choi, J.-K., Youm, S., Pareek, T., Levi, L., Kim, S.-J., Letterio, J., & Lim, S. (2026). The Dendritic Cell-based Vaccine PROTEXI leverages Antiviral CD4 T cell Memory to boost anti-tumor immune responses in mice. Nature Communications, 17(1). https://doi.org/10.1038/s41467-026-74891-3
2. Simmons, L. (2026, August 4). Innovative New Cancer Vaccine Weaponizes The Body’s Memory Of COVID-19 To Mount A “Coordinated, Supercharged Immune Attack.” IFLScience. https://www.iflscience.com/innovative-new-cancer-vaccine-weaponizes-the-bodys-memory-of-covid-19-to-mount-a-coordinated-supercharged-immune-attack-84286